Overview of Left Ventricular Thrombus Geoffrey Barnes, MD, MSc 17th Conference on Anticoagulation Therapy April 2, 2023 @GBarnesMD

Cardiac MRI (CMR) is useful for inconclusive or non-diagnostic echocardiogram exams when LV thrombus is suspected. CMR can also differentiate thrombus from other intracardiac masses (e.g. …

Themes include: aspirin vs. anticoagulants for VTE prevention after hip/knee arthroplasty, AC management in athletes, updated ASH/ISTH pediatric VTE treatment guidelines, cardioversion …

Study Design: A post-hoc analysis of the ELAN trial, which was an RCT that investigated early (<48 hours after ischemic stroke for minor and moderate stroke, 6–7 days for major stroke) vs late DOAC …

Safety evaluation of electrical cardioversion in the presence of LV thrombus Background: Historically, the presence of left ventricular thrombus (LVT) has been a contraindication to cardioversion due to a …

Dec 29, 2025 · DOAC-Sensitive Testing: Emerging Evidence, Practical Applications, and What’s Next This webinar will review the latest evidence on DOAC-sensitive testing and explore emerging testing …

Mar 6, 2017 · Congestive heart failure/LV 1 0 0 dysfunction Hypertension⁎ 1 1 1.3 Age ≥ 75 years 2 2 2.2 Diabetes mellitus 1 3 3.2 Stroke, TIA or 2 4 4.0 thromboembolism Vascular disease⁎⁎ 1 5 6.7 …

The Resource Center is a repository of clinical resources and tools, expertly curated all in one place. Hundreds of resources are organized by overarching headings from most broad guidance. Click here …

ANTICOAGULATION STEWARDSHIP: A CALL TO ACTION The overall use of anticoagulants has increased markedly over time and consequently we have seen higher percentages of anticoagulant …

Future Directions In Non-cardioembolic Secondary Stroke Platelet activation and clot initiation leads to primary and secondary hemostasis. Clot amplification is initiated by the thrombin generated from …